Ubs Group Ag Gsk PLC Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$42.05 - $47.77 $7.49 Million - $8.51 Million	178,152 Added 16.21%	1,277,193 $55.6 Million
Q1 2022 May 16, 2022	SELL	$40.23 - $47.74 $2.41 Million - $2.86 Million	-60,011 Reduced 5.18%	1,099,041 $47.9 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $236 Million - $275 Million	-6,079,888 Reduced 83.99%	1,159,052 $51.1 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $7.84 Million - $8.72 Million	-202,026 Reduced 2.72%	7,238,940 $277 Million
Q2 2021 Aug 13, 2021	SELL	$36.52 - $41.46 $35.1 Million - $39.9 Million	-961,914 Reduced 11.45%	7,440,966 $296 Million
Q1 2021 May 12, 2021	BUY	$34.27 - $40.01 $241 Million - $281 Million	7,023,741 Added 509.28%	8,402,880 $300 Million
Q4 2020 Feb 11, 2021	SELL	$34.07 - $39.94 $432,484 - $506,998	-12,694 Reduced 0.91%	1,379,139 $50.8 Million
Q3 2020 Nov 12, 2020	SELL	$38.11 - $42.99 $3.56 Million - $4.01 Million	-93,360 Reduced 6.29%	1,391,833 $52.4 Million
Q2 2020 Jul 31, 2020	SELL	$37.87 - $43.58 $2.27 Million - $2.61 Million	-59,881 Reduced 3.88%	1,485,193 $60.6 Million
Q1 2020 May 01, 2020	BUY	$32.47 - $48.83 $4.22 Million - $6.35 Million	130,072 Added 9.19%	1,545,074 $58.5 Million
Q4 2019 Feb 14, 2020	BUY	$42.0 - $48.25 $285,558 - $328,051	6,799 Added 0.48%	1,415,002 $66.5 Million
Q3 2019 Nov 14, 2019	BUY	$40.46 - $43.52 $7.08 Million - $7.61 Million	174,915 Added 14.18%	1,408,203 $60.1 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $3.21 Million - $3.48 Million	-81,508 Reduced 6.2%	1,233,288 $49.4 Million
Q1 2019 May 14, 2019	SELL	$38.57 - $42.69 $4.27 Million - $4.73 Million	-110,782 Reduced 7.77%	1,314,796 $54.9 Million
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $2.18 Million - $2.46 Million	-57,585 Reduced 3.88%	1,425,578 $54.5 Million
Q3 2018 Nov 14, 2018	BUY	$39.75 - $42.69 $583,053 - $626,176	14,668 Added 1.0%	1,483,163 $59.6 Million
Q2 2018 Aug 14, 2018	SELL	$39.61 - $42.76 $4.04 Million - $4.36 Million	-101,917 Reduced 6.49%	1,468,495 $59.2 Million
Q1 2018 May 15, 2018	BUY	$36.18 - $40.15 $4.85 Million - $5.38 Million	133,915 Added 9.32%	1,570,412 $61.4 Million
Q4 2017 Feb 14, 2018	SELL	$35.34 - $41.9 $2.93 Million - $3.48 Million	-82,970 Reduced 5.46%	1,436,497 $51 Million
Q3 2017 Nov 14, 2017	SELL	$39.44 - $41.55 $26.3 Million - $27.7 Million	-667,629 Reduced 30.53%	1,519,467 $61.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	33,145 Added 1.54%	2,187,096 $94.3 Million
Q1 2017 Nov 14, 2017	BUY	N/A	2,153,951	2,153,951 $90.8 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account

Ubs Group Ag Gsk PLC Transaction History

Ubs Group Ag

Shares

Others Institutions Holding GSK

# of Institutions

Shares Held

Call Options Held

Put Options Held

About GSK PLC

Track Ubs Group Ag Portfolio

Portfolio Update

News